Eli Lilly LLY
NYSE LLY
$1,354.49 -10.24 (-0.75%)
At close: Nov 6, 2026 · 4:00 PM EST

Eli Lilly (LLY) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Eli Lilly (LLY) posted Return on Capital Employed [ROCE] of 43.74% for Q3 2026, up 5.91 percentage points from 37.83% a year earlier but down 2.99 percentage points from the prior quarter.

Analysis

Eli Lilly (LLY) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Eli Lilly's Return on Capital Employed [ROCE] came in at 48.39%, up 10.75 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has increased for eight consecutive years, with a five-year change of +25.99 percentage points (FY2020 to FY2025).
  • In prior years, Eli Lilly's Return on Capital Employed [ROCE] was 37.64% in FY2024 (+2.82 pp), 34.82% in FY2023 (+9.72 pp), 25.10% in FY2022 (+2.67 pp) and 22.43% in FY2021 (+0.03 pp).
  • Quarterly Return on Capital Employed [ROCE] has run from a low of 20.00% in Q1 2023 to a high of 46.74% in Q2 2026 over five years.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last 13 quarters, with an average year-over-year change of +6.93 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2025, with a gain of 10.02 percentage points; the weakest was Q2 2023, with a drop of 5.75 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 46.74% (Q2 2026), 42.94% (Q1 2026) and 37.22% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 43.74%
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.52%
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 21.60%
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 5.33%
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 9.91%
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -6.15%
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 11.32%
10 Vertex Pharmaceuticals 138.73 Bn 110.72 Bn 2.91 Bn 17.16%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 43.74%
Jun 30, 2026 46.74%
Mar 31, 2026 42.94%
Dec 31, 2025 37.22%
Sep 30, 2025 37.83%
Jun 30, 2025 39.15%
Mar 31, 2025 34.87%
Dec 31, 2024 33.16%
Sep 30, 2024 28.23%
Jun 30, 2024 31.69%
Mar 31, 2024 24.85%
Dec 31, 2023 30.47%
Sep 30, 2023 27.13%
Jun 30, 2023 21.77%
Mar 31, 2023 20.00%
Dec 31, 2022 25.64%
Sep 30, 2022 26.30%
Jun 30, 2022 27.52%
Mar 31, 2022 24.45%
Dec 31, 2021 21.91%
API Access

Eli Lilly Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LLY&period=max&api_key=YOUR_API_KEY